Cargando…
EGFR exon 20 insertion mutations in non-small cell lung cancer
Mutations in the epidermal growth factor receptor (EGFR) gene are the most common targetable genomic drivers of non-small cell lung cancer (NSCLC). 90% of the EGFR mutations comprise of EGFR exon 19 deletion and exon 21 L858R mutation, while EGFR exon 20 insertion (EGFR Ex20Ins) is the third most co...
Autores principales: | Wang, Fenfang, Li, Chenghui, Wu, Qihuan, Lu, Hongyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799012/ https://www.ncbi.nlm.nih.gov/pubmed/35117654 http://dx.doi.org/10.21037/tcr.2020.03.10 |
Ejemplares similares
-
Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
por: Vyse, Simon, et al.
Publicado: (2019) -
EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer
por: Fang, Wenfeng, et al.
Publicado: (2019) -
Advances in the management of non-small-cell lung cancer harbouring
EGFR exon 20 insertion mutations
por: Low, Jia Li, et al.
Publicado: (2023) -
Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea
por: Byeon, Seonggyu, et al.
Publicado: (2019) -
EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives
por: Hou, Jiabao, et al.
Publicado: (2022)